简
/
繁
/
EN
About Us
R&D
Products
News
Careers
Investors
Contact us
Investors
（02186.HK）
HK$
➚
%
Volume(M)
0thousand
Turnover(HK $)
0thousand
Data as of：
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Year
2022
2023
2024
2025
2026
13
2026-05
VOLUNTARY ANNOUNCEMENT ON-MARKET SHARE REPURCHASE
07
2026-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
29
2026-04
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
29
2026-04
ANNUAL REPORT 2025
28
2026-04
PROPOSED ADOPTION OF RESTRICTED SHARE UNIT INCENTIVE SCHEME
26
2026-04
VOLUNTARY ANNOUNCEMENT CDE ACCEPTANCE OF PHASE II CLINICAL TRIAL APPLICATION FOR BA1106 IN COMBINATION WITH BA1104 FOR NSCLC
08
2026-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
31
2026-03
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
31
2026-03
(1) RESIGNATION OF EXECUTIVE DIRECTOR; AND (2) CHANGE IN COMPOSITION OF BOARD COMMITTEE
30
2026-03
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
1
2
3
4
5
Follow me
鲁公网安备37069102000284